Cargando…

Effect of the African Traditional Medicine, Sutherlandia frutescens, on the Bioavailability of the Antiretroviral Protease Inhibitor, Atazanavir

The objective of this study was to investigate the effect of Sutherlandia frutescens (SF) on the bioavailability of atazanavir (ATV) in twelve healthy male subjects. During Phase I (Day 1), subjects ingested a single dose of ATV and blood samples were drawn before dose and at 0.5, 1.0, 1.5, 2.0, 2.5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Adrienne C., Skinner, Michael F., Kanfer, Isadore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876690/ https://www.ncbi.nlm.nih.gov/pubmed/24416065 http://dx.doi.org/10.1155/2013/324618

Ejemplares similares

African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology
por: Mills, Edward, et al.
Publicado: (2005)

Sutherlandia frutescens may exacerbate HIV-associated neuroinflammation
por: Africa, Luan Dane, et al.
Publicado: (2015)

An Investigation into the Immunomodulatory Activities of Sutherlandia frutescens in Healthy Mice
por: Lei, Wei, et al.
Publicado: (2016)

The mutagenic and antimutagenic activity of Sutherlandia frutescens extracts and marker compounds
por: Ntuli, Siyabulela S. B. N., et al.
Publicado: (2018)

The Induction of Apoptosis in A375 Malignant Melanoma Cells by Sutherlandia frutescens
por: van der Walt, Nicola B., et al.
Publicado: (2016)

Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled Trial
por: Wilson, Douglas, et al.
Publicado: (2015)

Inhibition of Hedgehog-Signaling Driven Genes in Prostate Cancer Cells by Sutherlandia frutescens Extract
por: Lu, Yuan, et al.
Publicado: (2015)

Sutherlandia frutescens Ethanol Extracts Inhibit Oxidative Stress and Inflammatory Responses in Neurons and Microglial Cells
por: Jiang, Jinghua, et al.
Publicado: (2014)

Anticancer Potential of Sutherlandia frutescens and Xysmalobium undulatum in LS180 Colorectal Cancer Mini-Tumors
por: Gouws, Chrisna, et al.
Publicado: (2021)

Antioxidant potential of Sutherlandia frutescens and its protective effects against oxidative stress in various cell cultures
por: Tobwala, Shakila, et al.
Publicado: (2014)

Isolation of alpha-linolenic acid from Sutherlandia frutescens and its inhibition of Mycobacterium tuberculosis’ shikimate kinase enzyme
por: Masoko, Peter, et al.
Publicado: (2016)

The effect of Aspalathin linearis, Cyclopia intermedia and Sutherlandia frutescene on sperm functional parameters of healthy male wistar rats
por: Omolaoye, Temidayo S., et al.
Publicado: (2023)

Comparative cardio and developmental toxicity induced by the popular medicinal extract of Sutherlandia frutescens (L.) R.Br. detected using a zebrafish Tuebingen embryo model
por: Chen, Longsheng, et al.
Publicado: (2018)

Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations
por: Rhee, Soo-Yon, et al.
Publicado: (2022)

The Implication of Chemotypic Variation on the Anti-Oxidant and Anti-Cancer Activities of Sutherlandia frutescens (L.) R.Br. (Fabaceae) from Different Geographic Locations
por: Zonyane, Samkele, et al.
Publicado: (2020)

The Effect of Rooibos (Aspalathus linearis), Honeybush (Cyclopia intermedia) and Sutherlandia (Lessertia frutescens) on Testicular Insulin Signalling in Streptozotocin-Induced Diabetes in Wistar Rats
por: Omolaoye, Temidayo S, et al.
Publicado: (2021)

Monomorphic ventricular tachycardia due to protease inhibitor intoxication by atazanavir
por: Kim, Byunghyun, et al.
Publicado: (2018)

Screening, Purification and Characterization of Protease Inhibitor from Capsicum frutescens
por: Mohan, Manju, et al.
Publicado: (2018)

Perilla frutescens: A traditional medicine and food homologous plant
por: Wu, Xinling, et al.
Publicado: (2023)

Is Ritonavir-Boosted Atazanavir a Risk for Cholelithiasis Compared to Other Protease Inhibitors?
por: Hamada, Yohei, et al.
Publicado: (2013)

Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir
por: Jose, Sophie, et al.
Publicado: (2017)

DFT investigation of atazanavir as potential inhibitor for 2019-nCoV coronavirus M protease
por: Shahab, Siyamak, et al.
Publicado: (2021)

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
por: Antoniou, Tony, et al.
Publicado: (2017)

A Validated IVRT Method to Assess Topical Creams Containing Metronidazole Using a Novel Approach
por: Rath, Seeprarani, et al.
Publicado: (2020)

In Vitro–In Vivo Correlations (IVIVC) for Predicting the Clinical Performance of Metronidazole Topical Creams Intended for Local Action
por: Rath, Seeprarani, et al.
Publicado: (2023)

Atazanavir versus lopinavir on Covid-19 infection: A retrospective protease inhibitors comparative study 2020
por: Alikhani, Ahmad, et al.
Publicado: (2022)

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
por: Wiesmann, Frank, et al.
Publicado: (2011)

Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
por: Ma, Chunlong, et al.
Publicado: (2021)

Pharmacokinetic-pharmacodynamic modelling of atazanavir in hair among adolescents on antiretroviral treatment in Zimbabwe
por: Ngara, Bernard, et al.
Publicado: (2021)

Atazanavir nephrotoxicity
por: Hara, Masaki, et al.
Publicado: (2015)

Antenatal Atazanavir: A Retrospective Analysis of Pregnancies Exposed to Atazanavir
por: Samuel, Miriam, et al.
Publicado: (2014)

Validation of Simultaneous Quantitative Method of HIV Protease Inhibitors Atazanavir, Darunavir and Ritonavir in Human Plasma by UPLC-MS/MS
por: Mishra, Tulsidas, et al.
Publicado: (2014)

Repurposing HIV Protease Inhibitors Atazanavir and Darunavir as Antifungal Treatments against Candida albicans Infections: An In Vitro and In Vivo Study
por: Fenley, Juliana de C., et al.
Publicado: (2022)

Acute development of Cushing syndrome in an HIV-infected child on atazanavir/ritonavir based antiretroviral therapy
por: Dubrocq, Gueorgui, et al.
Publicado: (2017)

Pharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients
por: Orrell, Catherine, et al.
Publicado: (2015)

Effects of a switch from tenofovir- to abacavir-based antiretroviral therapy, with or without atazanavir, on renal function
por: Guillemi, Silvia A, et al.
Publicado: (2016)

Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population
por: Rusconi, Stefano, et al.
Publicado: (2012)

External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients
por: Rekić, Dinko, et al.
Publicado: (2012)

A Novel Approach to Assess the Potency of Topical Corticosteroids
por: Zvidzayi, Michael, et al.
Publicado: (2021)

Correction: Zvidzayi et al. A Novel Approach to Assess the Potency of Topical Corticosteroids. Pharmaceutics 2021, 13, 1456
por: Zvidzayi, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s57bu3clg1l4pdcf6fifv0j0pu